Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Elena Rivolti"'
Autor:
Mattia D’agostino, Davine Hofste Op Bruinink, Mark van Duin, Delia Rota-Scalabrini, Luca Bertamini, Rowan Kuiper, Angelo Belotti, Vincenzo Marasco, Stefania Oliva, Elena Rivolti, Jennifer Rogers, Roberto Mina, Mariella Grasso, Antonio Ledda, Massimo Offidani, Monica Galli, Michele Cavo, Annemiek Broijl, Pellegrino Musto, Benedetto Bruno, Mario Boccadoro, Pieter Sonneveld, Francesca Gay
Publikováno v:
HemaSphere, Vol 7, p e36094ab (2023)
Externí odkaz:
https://doaj.org/article/3b796f80d4e14f24afec4a2aa1b32606
Autor:
Bruno Fattizzo, Valentina Carrai, Monica Crugnola, Erminia Baldacci, Marta Bellini, Costanza Bosi, Elisa Buzzatti, Domenica Caramazza, Giuseppe Carli, Monica Carpenedo, Cristina Clissa, Cristina Danesin, Maria Rosaria De Paolis, Juri Alessandro Giannotta, Vanessa Innao, Monia Marchetti, Uros Markovic, Alessandro Morotti, Mariasanta Napolitano, Andrea Patriarca, Loredana Pettine, Antonella Poloni, Elena Rivolti, Elena Rossi, Teresa Maria Santeremo, Cristina Santoro, Maria Elena Zannier, Francesco Zaja, Silvia Cantoni, Francesca Palandri, Valerio De Stefano
Publikováno v:
HemaSphere, Vol 7, p e024400a (2023)
Externí odkaz:
https://doaj.org/article/a80eb4b9d83b4b959bc96aa6ee514995
Autor:
Nicola Vianelli, Giuseppe Auteri, Francesco Buccisano, Valentina Carrai, Erminia Baldacci, Cristina Clissa, Daniela Bartoletti, Gaetano Giuffrida, Domenico Magro, Elena Rivolti, Daniela Esposito, Gian Marco Podda, Francesca Palandri
Publikováno v:
Annals of hematology. 101(5)
Chronic primary immune thrombocytopenia (ITP) can today benefit from multiple therapeutic approaches with proven clinical efficacy, including rituximab, thrombopoietin receptor agonists (TPO-RA), and splenectomy. However, some ITP patients are unresp
Autor:
Valerio De Stefano, Lucia Pantani, Sonia Morè, Simona Barbato, Luca Dozza, Michele Cea, Alessio Fusco, Maria Teresa Petrucci, Alessandro Gozzetti, Patrizia Tosi, Michele Cavo, Gabriella De Cicco, Elisabetta Antonioli, Paola Tacchetti, Katia Mancuso, Mattia D'Agostino, Serena Rocchi, Elena Rivolti, Elena Zamagni, Ilaria Rizzello
Publikováno v:
Leukemialymphoma. 62(8)
Subcutaneous (SC) bortezomib-based regimens represent the standard induction therapy prior to autologous stem cell transplantation (ASCT) in newly diagnosed multiple myeloma patients. Published data are based principally on intravenous (IV) administr
Autor:
Wilma Barcellini, Michele Cavo, Emanuele Sutto, Francesca Palandri, Andrea Patriarca, Daniela Bartoletti, Erminia Baldacci, Gaetano Giuffrida, Francesco Zaja, Monica Carpenedo, Ugo Consoli, Antonietta Ferretti, Federico Chiurazzi, Daniela Nicolosi, Elena Rivolti, Giuseppe Auteri, Esther Oliva, Maria Gabriella Mazzucconi, Elisa Lucchini, Silvia Cantoni, Giuseppe Carli, Valerio De Stefano, Nicola Vianelli, Giovanni Caocci, Francesco Rodeghiero, Elena Rossi, Valentina Carrai, Alessandra Borchiellini, Marco Ruggeri
The efficacy and safety of thrombopoietin receptor agonists (TRAs) in older patients with primary immune thrombocytopenia (ITP) are unknown. We investigated TRA response and switch, thrombotic/hemorrhagic risk, and sustained responses off-treatment (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84dfa4013b2d76cb869451f0229a562b
https://ashpublications.org/blood/article-abstract/138/7/571/475829/
https://ashpublications.org/blood/article-abstract/138/7/571/475829/
Autor:
Evangelos Terpos, Magdalini Migkou, Argiris Symeonidis, Michele Cavo, Efstathios Kastritis, Eirini Katodritou, Nikolaos Kanellias, Maria Gavriatopoulou, Sosana Delimpasi, Marie-Christine Kyrtsonis, Meletios A. Dimopoulos, Evdoxia Hatjiharissi, Alexandros Leonidakis, Maria Roussou, Despina Fotiou, Elena Rivolti, Elena Zamagni, Kyriaki Manousou
Publikováno v:
Blood. 138:2729-2729
Introduction Despite the availability of novel agents in treating multiple myeloma (MM), renal impairment (RI) remains a poor prognostic factor, and the median survival of patients (pts) with MM and RI is approximately half of that for MM pts with no
Autor:
Elena Zamagni, Cristina Nanni, Francesca Gay, Luca Dozza, Delia Rota Scalabrini, Mattia D'Agostino, Rossella Ribolla, Monica Galli, Manuela Racca, Renato Zambello, Elena Rivolti, Domenico Albano, Annibale Versari, Mariella Grasso, Rossella Troia, Antonio Spadano, Francesca Patriarca, Marina Ruggeri, Marco Rensi, Anna Pascarella, Pietro Zucchetta, Paola Tacchetti, Stefano Fanti, Mario Boccadoro, Michele Cavo, Pellegrino Musto, Stefania Oliva
Publikováno v:
Blood. 136:27-28
Background: 18F-FDG-PET/CT is currently the standard technique to define imaging-minimal residual disease (MRD) in multiple myeloma (MM) patients. A joint analysis of 2 prospective randomized trials in newly diagnosed transplant-eligible MM (NDTEMM)
Autor:
Efstathios Kastritis, Maria Roussou, Nikolaos Kanellias, Magdalini Migkou, Marie-Christine Kyrtsonis, Despina Fotiou, Eirini Katodritou, Evangelos Terpos, Meletios A. Dimopoulos, Sosana Delimpasi, Elena Rivolti, Elena Zamagni, Argiris Symeonidis, Maria Gavriatopoulou, Michele Cavo, Evdoxia Hatjiharissi
Publikováno v:
Blood. 136:48-49
Introduction: Renal impairment (RI) is common in multiple myeloma (MM), with up to 40% of the patients (pts) experiencing this complication during the course of their disease. RI increases risk of early death and affects disease management in multipl
Autor:
Michele Cavo, Francesco Rotondo, Lucia Catani, Marco Ruggeri, Monica Carpenedo, Erminia Baldacci, Silvia Cantoni, Alessandro Lucchesi, Emanuele Sutto, Daniela Bartoletti, Francesca Palandri, Giuseppe Carli, Francesco Rodeghiero, Elena Rossi, Valentina Carrai, Christian Di Pietro, Cristina Santoro, Maria Gabriella Mazzucconi, Wilma Barcellini, Nicola Vianelli, Elena Rivolti, Valerio De Stefano, Giuseppe Auteri
Publikováno v:
Thrombosis research. 185
INTRODUCTION: Primary Immune thrombocytopenia (ITP) in the elderly is a major clinical challenge which is increasingly frequent due to global ageing population. MATERIALS AND METHODS: To describe baseline ITP features, management, and outcome, a cent
Autor:
Monika Szarejko, Stefan Knop, Jan Dürig, Bansod Sudhir, Guy Lemaillet, Elena Rivolti, Hartmut Goldschmidt, Mattia D'Agostino, Barbara Gamberi, Artur Jurczyszyn, Sara Bringhen, Doris Lang, Angelo Vacca, Roberto Ria, Jorge Castellano Acosta, Norbert Grząśko, Marc S. Raab
Background Bone marrow neovascularization is a hallmark of multiple myeloma and progression is associated with a substantial increase in pro-angiogenic factors that promote bone marrow angiogenesis, including vascular endothelial growth factor (VEGF-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc70a0a6254da54d0425d6e4072934c8